Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Karma Ventures
Symptom checker Infermedica scores $3.65M, continues move into US market
By
Laura Lovett
|
01:03 pm |
June 05, 2019
Backed by Karma Ventures, Dreamit Ventures, Inovo Venture Partners and Müller Medien, the Polish-born company plans to expand its US team.